businesspress24.com - Ogilvy CommonHealth Worldwide's John Nosta to Moderate TEDMED "Great Challenges" Vide
 

Ogilvy CommonHealth Worldwide's John Nosta to Moderate TEDMED "Great Challenges" Video Discussions

ID: 1185859

(firmenpresse) - PARSIPPANY, NJ -- (Marketwire) -- 01/10/13 -- Ogilvy CommonHealth Worldwide (), the health behavior experts of Ogilvy & Mather (), announced John Nosta, EVP, Strategy at Ogilvy CommonHealth Specialty Marketing has been tapped to moderate today's "Achieving More Medical Innovation, More Affordably" and "Eliminating Medical Errors" video panel discussions, at 1 PM and 3 PM (EST), as part of TEDMED's 20 Great Challenges of Health and Medicine Program.

Ogilvy CommonHealth Worldwide is a WPP company (NASDAQ: WPPGY) (). The organization houses and maintains individual Ogilvy CommonHealth and Ogilvy Healthworld brand identities within the marketplace.

TEDMED is a platform for the multidisciplinary community of innovators and leaders in health and medicine who share a common vision to communicate the challenges and opportunities in healthcare, aiming to foster further advancements in the field. The Great Challenges Program is a series of 20 live, web-based discussions (held every Thursday through March 2013) that covers specific healthcare topics chosen by the TEDMED community. For each panel, a different Challenge Team is assembled, consisting of a multidisciplinary group of leaders in various healthcare areas, each of whom brings a passionate and thoughtful perspective. Attendees of the live panel are encouraged to participate by posting comments and follow-up questions, and engaging in real-time dialog with all members of a Challenge Team, as well as other members of the TEDMED community.

In today's panels, John Nosta will be moderating two different Challenge Teams. The first group addresses the various models that could be applied effectively to achieve faster, yet less costly, innovations in health and medicine. The second group discusses the reduction and elimination of medical errors. For more information or to view these webcasts, please visit .

Ogilvy CommonHealth Worldwide is committed to creativity and effectiveness in healthcare communications, everywhere. With 63 offices across 33 countries, the group provides marketing services including brand identity and development, clinical trial recruitment, digital/interactive services, direct-to-consumer, direct-to-patient, global integration, managed care marketing, market research and analytics, media planning and buying, medical advertising and promotion, medical education, public affairs and relations, relationship marketing, and strategic consulting. The network also offers scientific communications and publications services through a wholly owned separate legal entity.







Contact:
Beth Paulino
Kerianne Slattery
Ogilvy CommonHealth Worldwide
973.352.1000 tel


Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  CytoSorbents 2012 End of Year Shareholder Letter
La Jolla Pharmaceutical Company Adds to Management Team
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 10.01.2013 - 06:00 Uhr
Sprache: Deutsch
News-ID 1185859
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

PARSIPPANY, NJ


Phone:

Kategorie:

Health & Nutrition


Anmerkungen:


Diese Pressemitteilung wurde bisher 136 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Ogilvy CommonHealth Worldwide's John Nosta to Moderate TEDMED "Great Challenges" Video Discussions
"
steht unter der journalistisch-redaktionellen Verantwortung von

Ogilvy CommonHealth Worldwide (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Ogilvy CommonHealth Worldwide



 

Who is online

All members: 10 565
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 76


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.